Clinical Translation of Cell Therapy, Tissue Engineering, and Regenerative Medicine Product in Malaysia and Its Regulatory Policy
- 19 August 2015
- journal article
- research article
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 21 (23-24) , 2812-2816
Abstract
With the worldwide growth of cell and tissue therapy (CTT) in treating diseases, the need of a standardized regulatory policy is of paramount concern. Research in CTT in Malaysia has reached stages of clinical trials and commercialization. In Malaysia, the regulation of CTT is under the purview of the National Pharmaceutical Control Bureau (NPCB), Ministry of Health (MOH). NPCB is given the task of regulating CTT, under a new Cell and Gene Therapy Products framework, and the guidelines are currently being formulated. Apart from the laboratory accreditation, researchers are advised to follow Guidelines for Stem Cell Research and Therapy from the Medical Development Division, MOH, published in 2009.Keywords
This publication has 14 references indexed in Scilit:
- Full-Thickness Skin Wound Healing Using Autologous Keratinocytes and Dermal Fibroblasts with FibrinAdvances in Skin & Wound Care, 2014
- Comparison of the effects between animal-derived trypsin and recombinant trypsin on human skin cells proliferation, gene and protein expressionCell and Tissue Banking, 2013
- The Global Cell Therapy Industry Continues to Rise during the Second and Third Quarters of 2012Cell Stem Cell, 2012
- The Survey on Cellular and Engineered Tissue Therapies in Europe in 2010Tissue Engineering Part A, 2012
- Correction: Shelf-Life Evaluation of Bilayered Human Skin Equivalent, MyDerm™PLOS ONE, 2012
- Cryopreservation of human vascular umbilical cord cells under good manufacturing practice conditions for future cell banksJournal of Translational Medicine, 2012
- Cell and tissue therapy regulation: Worldwide status and harmonizationBiologicals, 2012
- Regulatory enablers and regulatory challenges for the development of tissue-engineered products in the EUBio-Medical Materials and Engineering, 2010
- Reconstruction of living bilayer human skin equivalent utilizing human fibrin as a scaffoldBurns, 2007
- Biomedical Applications of Tissue Engineering Technology: Regulatory IssuesTissue Engineering, 1995